Acute intraoperative ischaemic cerebral oedema following torrential haemorrhage from the left intracranial internal carotid artery occurred during resection of a recurrent middle cranial fossa meningioma. A series of immediate anaesthetic interventions was effective in reducing brain oedema, allowed for surgical haemostasis, and resulted in no permanent sequelae to patient outcome. A review of the literature indicates that direct evidence for the efficacy of extremely early interventions as described in this case report is lacking and must be extrapolated from other brain injury models.
Acute and overt intraoperative cerebral oedema during open craniotomy may have multiple aetiologies, including ischaemia, global hypoxic-ischaemic insult from intraoperative haemodynamic/respiratory failure and cerebral venous outflow obstruction. It is frequently cytotoxic (ischaemic) in origin, relates to acute surgical disruption of the cerebral blood supply, tends to occur early in the course of the insult, and is only visually manifested during craniotomy. This is unlike cerebral oedema associated with stroke or primary brain trauma, which tends to occur earlier in the course of the insult but is only visually manifested during craniotomy. Rapid reversal of brain swelling is possible in acute intraoperative cerebral oedema due to ischaemia, and the delayed effects of brain swelling may potentially be further reduced with neuroprotective strategies.
CASE HISTORY
A 52-year-old woman presented for excision of a recurrent left middle cranial fossa meningioma. She had no other significant past medical history except for a history of carcinoma of the cervix with previous total hysterectomy and bilateral oopherectomy more than five years ago. Her current medications were phenytoin, dexamethasone and famotidine. She was 75 kg and examination was unremarkable except for mild hemiparesis, affecting the right upper and lower limb, and left third cranial nerve palsy.
Ten months earlier, she underwent gross total primary excision of a 5x5x6 cm left middle cranial fossa meningioma after presenting with headache, blunted affect and right-sided weakness. At primary excision, the tumour was found to encase the terminal left internal carotid artery, and portions of the left anterior cerebral artery and the left middle cerebral artery that arises from it. The tumour was adherent to the lateral wall of the cavernous sinus and displaced the optic nerve medially.
Postoperatively, she regained full activities of daily living, with mild right hemiparesis and third cranial nerve palsy. Repeat magnetic resonance imaging (MRI) at follow-up showed a recurrence of the tumour extending into the cavernous sinus and adherent to the left internal carotid artery, clivus and sella ( Figure 1 ).
The left internal carotid artery was patent. She was subsequently scheduled for elective excision of recurrent tumour.
Anaesthetic induction was with propofol and fentanyl. Maintenance was with balanced anaesthesia using isoflurane at end-tidal concentration of 0.6 to 0.7%, oxygen-nitrous oxide mixture in a 40:60 ratio, fentanyl boluses and atracurium. P a CO 2 was maintained at 30 mmHg using ETCO 2 after calibration with an arterial blood gas sample and body temperature was allowed to passively drift lower with the ambient temperature set at 20°C. A temperature probe was not used for this patient. Systolic blood pressure was maintained at 120 to 125 mmHg using labetalol. Intravenous normal saline was used as maintenance fluid.
Intraoperatively, most of the meningioma was removed piecemeal except for remnants around the cavernous portion of the internal carotid artery. When the frontal lobe was elevated to check for tumour remnant, torrential haemorrhage occurred. Nitrous oxide was stopped and 100% oxygen was administered. Isoflurane was maintained at end-tidal concentration of 0.3%.
Over the next three minutes, definitive haemostasis could not be achieved. The brain started to swell around the dissection site, effectively tamponading the bleeding vessel. Systolic blood pressure fell to 85 to 95 mmHg and the following manoeuvres were applied: intravenous thiopentone 250 mg was given over 60 seconds, propofol infusion was started at 6 mg/kg/h for the first 10 minutes and then continued at 5 mg/kg/h; hyperventilation to achieve an estimated P a CO 2 of 25 mmHg was initiated. Intravenous ephedrine and rapid infusion of colloid and blood were used to maintain systolic blood pressure between 90 and 100 mmHg. Intravenous mannitol 30 g, equivalent to 0.4 g/kg body weight, was then infused rapidly followed by 10 mg of intravenous frusemide.
At this point, approximately ten minutes into the event, brain oedema subsided and brisk arterial bleeding recommenced and systolic blood pressure fell below 90 mmHg again. The left carotid artery was compressed digitally under the drapes while haemostasis was attempted. Bleeding was found to arise from a small hole in the intracranial portion of the left internal carotid artery. Haemostasis was secured with three aneurysm clips and digital compression of the left internal carotid artery was released after a total duration of approximately five minutes. The entire episode occurred over a period of approximately 20 to 25 minutes.
Surgery proceeded without further incident and the patient was transferred to the Intensive Care Unit (ICU) postoperatively for mechanical ventilation and neurological monitoring. She made an uneventful recovery the following day and regained full cognition after cessation of sedation and extubation. She had no new motor weakness, was mobilizing well and was discharged on the seventh postoperative day.
DISCUSSION
The acute brain swelling in this patient was likely to be the result of cellular energy failure secondary to ischaemia. The pathophysiology of cellular injury from ischaemia has been described in detail previously 1 .
The interventions sought for in acute intraoperative cerebral oedema are threefold. First, intervention is needed to provide optimal operative conditions for reversing the immediate cause of the oedema. This is directed at reducing brain volume to improve visualization of the surgical field for haemostasis and anatomical restoration of blood supply. These interventions include hyperventilation, osmotherapy and proximal arterial control. Second, measures must be taken to globally resuscitate the ischaemic brain. This requires restoration of adequate cerebral blood flow and brain oxygenation. Due to the lack of easily available direct measures of cerebral blood flow (CBF), cerebral perfusion pressure (CPP) is commonly used as a surrogate for adequate cerebral blood flow. Third, interventions that reduce the effects of hypoxia should be commenced. These include the use of induced hypothermia, cessation of nitrous oxide and maintenance of anaesthetic agents such as isoflurane, thiopentone or propofol. To what extent are these interventions evidencedbased?
Evidence from a rat focal ischaemia model by Neumann-Haefelin et al demonstrated that short periods of focal ischaemia (30 minutes) do not lead to blood brain barrier damage and blood brain barrier damage associated with vasogenic oedema is only significant with long occlusion times 2 . Rats were subjected to transient middle cerebral artery occlusion of varying duration (30, 60 minutes or 2.5 hours) and serial MRI images obtained at predetermined intervals (during occlusion, 0.5, 1.5, 2.5 hours and 1, 2, 7 days) after reperfusion. Diffused Weighted Imaging (DWI) abnormalities reversed transiently in the 30 minute ischaemia group (and partially also after 60 minutes) during early reperfusion but recurred after one day. After 2.5 hours of occlusion, DWI abnormalities were no longer reversed, and signal intensity on DWI images increased rapidly in previously ischaemic region due to blood brain barrier damage and oedema formation. Reversibility of ischaemic changes was demonstrated with early reperfusion in this model but delayed changes still occurred, probably due to secondary ischaemic damage. These findings suggest a role for neuroprotection during and after the ischaemic insult.
Mild hypothermia of 3 to 5°C has been shown to reduce infarct size in rats subjected to focal cerebral ischaemia 3 . The neuroprotective mechanism is unknown as mild hypothermia produces only a small reduction in cerebral metabolic rate (CMR). Proposed mechanisms include reduced extracellular fluid (ECF) glutamate levels, reduced N-methyl-D-aspartate (NMDA) receptor mediated calcium influx, diminished protein kinase C activity, suppressed nitric oxide synthase activity and reduced reperfusion free radical synthesis 4 . In animals, the tolerance for cerebral ischaemia is prolonged disproportionately during mild hypothermia at 34°C 5 . Results from two randomized clinical trials examining the use of hypothermia for neuroprotection are less definitive 6, 7 . No improvement in outcome or reduction in intracranial pressure (ICP) were demonstrated by Clifton in severe head-injured patients but Hindman, in a pilot study, showed reduced neurological deterioration postoperatively and increased good long-term outcome with the use of intraoperative hypothermia in patients with subarachnoid haemorrhage. However, these positive effects were not statistically significant and are still being examined in the subsequent Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) of Phase 2 trial. Clifton subsequently demonstrated that early hypothermia and subsequent maintenance of hypothermia in patients with head injury resulted in a better outcome 8 . In this patient, the use of early mild hypothermia and its maintenance may be beneficial because of its action on excitotoxin modulation, especially on the delayed effects of ischaemic cerebral oedema.
In acute focal brain ischaemia, cerebrovascular autoregulation to the undamaged brain is likely to be preserved 9 . Elevation of the cerebral perfusion pressure has immediate beneficial effects on oxygen delivery to the ischaemic penumbra. However, an inappropriately elevated CPP can result in an increase in brain volume secondary to increase in cerebral blood volume (CBV) further reducing flow despite increased perfusion pressure. This may occur when cerebrovascular autoregulation is impaired in a closed cranial vault. In an open craniectomy, ICP is atmospheric and mean arterial pressure (MAP) is equal to CPP in the absence of venous outflow obstruction. Inappropriate elevation of CPP may also contribute to disruption of blood brain barrier and vasogenic oedema. Data extrapolated from head injury models have indicated that maintenance of CPP above 70 mmHg may be associated with a substantial reduction in mortality and improvement in the quality of survival 10 . More recently, Steiner and colleagues have attempted to define an "optimal" CPP when autoregulation is intact in individual patients by using a pressure reactivity index based on a negative correlation between MAP and ICP measured continuously 11 .
Maintaining MAP above 60 mmHg may be adequate assuming cerebrovascular autoregulation is intact and ICP is atmospheric. This manoeuvre may have been advantageous in this patient as it may reduce blood loss and improve the surgical field. It is prudent, however, not to set MAP/CPP targets in isolation as concurrent use of volatile anaesthetics may blunt the coupling of blood flow to brain metabolism and shunt blood away from ischaemic regions to normal brain. This may potentially worsen ischaemia in the ischaemic penumbra.
Nitrous oxide causes an increase in ICP, CBF and CMR. However, CMR is increased disproportionately to CBF 12 . This may disrupt autoregulation and potentiate ischaemia. At the cellular level, nitrous oxide appears to be a non-specific NMDA antagonist. Although NMDA receptor activation occurs as part of cellular membrane failure, non-specific blockade of NMDA receptors by nitrous oxide may lead to a state of generalized disinhibition due to its inhibitory action on gamma amino butyric acid (GABA) transmission as well 13 . This may theoretically lead to an increase in excitotoxin release and potentiate cytotoxicity and cerebral oedema. Fast elimination and delivery of high-inspired oxygen concentration is appropriate in the setting of an ischaemic brain, especially when the ischaemia is causing cerebral oedema.
Isoflurane causes a barbiturate-like reduction in CMR. When administered alone, isoflurane was found to lower the critical cerebral blood flow threshold associated with ischaemic alterations on electroencephalography (EEG) 14 . At a cellular level, it antagonizes glutamate receptor-mediated calcium influx and is associated with a reduction in accumula-tion of lactate dehydrogenase in ischaemic brain tissue 15 . Isoflurane inhibition of the cytotoxic effects of the non-competitive NMDA receptor antagonist MK-801 has also been demonstrated 16 . The use of isoflurane in this patient may have some neuroprotective effects against hypoxia.
Hyperventilation is accepted as an effective shortterm method of reducing ICP by decreasing CBF and CBV. In normal brain, ischaemia may occur if P a CO 2 is reduced to less than 20 mmHg. There is a 40% reduction in CBF within 30 min after decreasing P a CO 2 by 15 to 20 mmHg, but four hours later, CBF is 90% of baseline. In addition there is an overshoot of 31% when P a CO 2 is restored to normal 17 . Hyperventilation to a P a CO 2 of 26 mmHg causes a 7.2% reduction in CBV and a 30.7% reduction in CBF 18 . It also decreases brain oxygen tension and jugular venous bulb desaturation. Hyperventilating this patient does reduce CBV and brain bulk but incurs the risk of inducing global ischaemia in the normal brain. There is no direct evidence that hyperventilation reduces brain water content or improves outcome in acute intraoperative cerebral oedema.
The use of barbiturate for neuroprotection is well known. These protective effects were initially believed to be due to its suppressive effects on CMR but were not reproducible when CMR was reduced with other agents 19, 20 . An animal study using barbiturates targeted to therapeutic endpoints of active EEG (low dose) or burst suppression EEG (high dose) had similar effects 21 . This finding suggests that high-dose barbiturate infusions, which have significant sideeffects, may not be required for neuroprotection. Two large prospective series have reported good results using thiopentone titrated to burst suppression in a focal ischaemia model (carotid endarterectomy) with stroke rates of 1.7% and 1.2% 22, 23 . It is undisputed that barbiturates are useful in lowering ICP in selected patients but their effect on outcome is not uniform. The optimal dosage, timing and method of administration are not known. The dose of thiopentone to produce burst suppression is approximately 3 to 7 mg/kg with its onset of action within 10 and 15 seconds and lasting for less than 5 to 10 minutes 24 . Clearly, the bolus dose used in this patient would not produce prolonged burst suppression. In addition to its CMR reduction effects, the barbiturate bolus may reduce the levels of excitotoxins released during ischaemia 25 and these actions may explain its protective effects at doses that only attenuate EEG. At present, there is only anecdotal evidence that thiopentone is useful in acute intraoperative cerebral oedema 26 .
Propofol has similar actions to barbiturates. Its global effects include a reduction in CMR and CBF with concomitant reduction in ICP and MAP. Its cellular effects include glutamate receptor antagonism at the NMDA receptor 27 and GABA receptor agonism. These actions support its ability to reduce excitotoxin release in cerebral ischaemia. Beneficial neuroprotective properties from animal data include comparative responses to barbiturates in neurologic outcome and infarct size in focal ischaemia 28 , attenuation of delayed neuronal death by preventing lipid peroxidation 29 and increased astrocytic uptake and retention of glutamate under oxidative stress 30 . If the neuroprotective effects of propofol can be proven in clinical studies, it would be superior to barbiturates as it does not present the problems associated with high dose or prolonged barbiturate infusion such as delayed awakening, immunosuppression and electrolyte abnormalities. At present, there is no direct evidence supporting its use for the treatment of intraoperative acute cerebral oedema. There are also no neuroprotective properties demonstrable in cardiac surgery patients 31 . Clinical experience suggests that prolonged, high-dose propofol infusion should be avoided because of reported fatalities due to cardiac failure in a retrospective ICU series where patients whose deaths were attributed to propofol infusion had received more than 58 hours of propofol at infusion rates of more than 5 mg/kg/h 32 . Its current use in focal ischaemia and cerebral oedema remains speculative.
Administration of mannitol leads to reduced ICP, improved CPP, increased CBF and reduced CMR. Schwartz demonstrated that mannitol improved mortality in patients with raised ICP secondary to diffuse cerebral oedema when compared to pentobarbitone (41% vs 77%) but this finding is not statistically significant 33, 34 . Its exact mechanism remains controversial. There is an immediate plasma-expanding effect followed by an osmotic effect, which begins about 15 to 30 minutes after administration 35 . Its duration of action is variable. Although not observed in this patient, very rapid administration of mannitol may result in hyperosmolar mediated vasodilatation and reduction in peripheral vascular resistance 36 . This can lead to a decrease in arterial pressure and reduction in cerebral perfusion pressure. There is no consistent neuroprotective effect demonstrated in 313 Permissive hypothermia Reduction of infarct size 3 5 Prolonged ischaemic tolerance 5 5 No ICP reduction and outcome improvement 6 1b Non significant reduction in postoperative neurological deterioration 7 2b Outcome improvement with early hypothermia and subsequent maintenance of hypothermia 8 2c CPP directed therapy CPP above 70 mmHg associated with reduction in mortality 10 1a Deterioration in pressure reactivity index for CPP >85 mmHg and <60 mmHg 11 2b
Nitrous oxide Increase in CMR more than increase in CBF 12 5 May increase excitotoxin release 13 5
Isoflurane Lowers critical cerebral blood flow associated with ischaemia 14 4 Reduced intracellular calcium influx and lactate dehydrogenase accumulation 15 5 Reduced cytotoxicity 16 5
Hyperventilation Reduction in CBF and CBV 17,18 2b Barbiturates Beneficial effects in focal ischaemia 19,20 5 EEG burst suppression not required for beneficial effects 21 5 Reduced stroke rates in focal ischaemia 22.23 2c Reduced levels of excitotoxins 25 4 Useful in acute intraoperative cerebral oedema 26 5
Propofol Beneficial effects comparable to barbiturates 28,29,30 5 No neuroprotective properties in cardiac surgery patients 31 1b
Osmotherapy (mannitol and frusemide) Combined use may prolong effects of mannitol 37 5 Digital compression Arterial occlusion may reduce vasogenic oedema 38 5 animals in terms of lesion/infarct size. Concomitant use of loop diuretics is advocated but not evidencebased and limited data suggest that its use may prolong the effects of mannitol 37 . Digital compression was used in this case as a method of providing some proximal control to improve surgical exposure. Arterial occlusion may reduce vasogenic cerebral oedema 38 but such measures may worsen both ischaemia and oedema during reperfusion if other measures such as osmotherapy are not instituted.
The interventions used in the management of this patient are summarized in Table 1 .
There are no randomized control trials comparing the effects of one intervention versus another in acute intraoperative cerebral oedema. Measures used to treat this condition continue to be based on the underlying pathophysiology of acute cerebral oedema and treatment options extrapolated from other models. Further elucidation of the cellular mechanism involved in hypoxic membrane failure and clinical evidence to support definitive beneficial therapies will guide future choices.
